Institut Curie

This early-phase study tested a combination of two experimental drugs, tuvusertib and PLX038, in people with advanced solid tumors that had not responded to prior treatments. The goal was to find a safe dose and see if the drugs could shrink tumors. The trial was terminated early…

This early-phase trial tested a drug called PF-05212384 in people with certain acute myeloid leukemias or related blood cancers that came back or didn't respond to treatment. Only 10 people were enrolled before the study was stopped. The goal was to see if the drug could shrink o…

This study tested a new drug called PLX038 in 14 people with advanced triple-negative breast cancer that had already been treated. The goal was to see if the drug could shrink tumors. The trial was stopped early, so results are limited.

This study looked at whether special hemostatic dressings can reduce bleeding when changing bandages on bleeding cancer wounds. Four adults with malignant wounds participated. Researchers compared bleeding and pain between hemostatic and regular dressings. The goal was to find a …

This study looked at whether measuring tumor DNA in the blood of cervical cancer patients can help find small amounts of cancer that have spread early on. Researchers enrolled 26 patients with cervical cancer at any stage before treatment. They collected blood samples over time t…